down arrow

Natco Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
933.60
-15.65 (-1.65%)
BSENSE

Dec 05

BSE+NSE Vol: 8.82 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
35.80
35.80
36.50
36.50
36.50
36.40
Share Warrants & Outstandings
Total Reserve
7,571.20
5,817.30
4,837.30
4,223.70
4,067.60
3,713.60
Shareholder's Funds
7,607.00
5,853.10
4,873.80
4,263.60
4,121.60
3,773.50
Minority Interest
5.30
0.00
0.00
0.00
1.80
11.20
Long-Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.90
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.90
Deferred Tax Assets / Liabilities
-49.90
-19.20
12.40
30.10
41.30
25.90
Other Long Term Liabilities
9.2
9.3
2.8
9.3
2
0.8
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
65.60
70.90
85.30
95.70
99.60
90.20
Total Non-Current Liabilities
24.90
61.00
100.50
135.10
142.90
117.80
Current Liabilities
Trade Payables
274.90
235.50
263.80
161.80
146.20
255.40
Other Current Liabilities
317.60
271.20
237.40
127.60
100.80
104.40
Short Term Borrowings
273.10
363.20
165.00
404.00
265.80
315.00
Short Term Provisions
77.90
102.90
16.90
17.00
12.80
10.50
Total Current Liabilities
943.50
972.80
683.10
710.40
525.60
685.30
Total Liabilities
8,580.70
6,886.90
5,657.40
5,109.10
4,791.90
4,587.80
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
4,016.10
3,603.20
3,375.10
3,126.90
2,702.10
2,148.70
Less: Accumulated Depreciation
1,268.10
1,112.40
948.20
815.10
678.90
564.30
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
2,698.00
2,490.80
2,426.90
2,311.80
2,023.20
1,584.40
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
225.40
137.30
64.30
129.50
223.40
518.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
152.80
95.90
87.30
104.40
151.90
83.60
Long Term Loans & Advances
77.70
114.00
78.30
73.00
45.10
72.60
Other Non Current Assets
156.80
25.40
0.30
3.70
3.50
3.60
Total Non-Current Assets
3,310.70
2,863.40
2,657.10
2,622.40
2,447.10
2,262.20
Current Assets Loans & Advances
Current Investments
320.80
443.50
305.00
203.70
151.80
28.70
Inventories
765.80
700.50
742.90
762.00
798.20
558.00
Sundry Debtors
1,246.60
1,188.90
856.10
620.60
412.90
551.30
Cash and Bank
2,176.00
952.90
546.30
206.10
283.50
66.00
Other Current Assets
135.10
99.50
63.40
88.10
94.70
91.60
Short Term Loans and Advances
625.70
638.20
486.60
606.20
603.70
1,030.00
Total Current Assets
5,270.00
4,023.50
3,000.30
2,486.70
2,344.80
2,325.60
Net Current Assets (Including Current Investments)
4,326.50
3,050.70
2,317.20
1,776.30
1,819.20
1,640.30
Total Current Assets Excluding Current Investments
4,949.20
3,580.00
2,695.30
2,283.00
2,193.00
2,296.90
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
8,580.70
6,886.90
5,657.40
5,109.10
4,791.90
4,587.80
Contingent Liabilities
3.00
0.40
14.60
8.00
1.20
1.10
Total Debt
273.10
363.20
165.00
404.00
265.80
315.90
Book Value per share (adjusted)
424.97
326.99
267.06
233.62
225.84
207.34
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -24.81% vs 120.12% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -1.08% vs 232.14% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 11.24% vs 5.50% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 59.33% vs 9.85% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 30.98% vs 34.10% in Mar 2024

Compare Balance Sheet Results of Natco Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
35.80
15.80
20.00
126.58%
Share Warrants & Outstandings
Total Reserve
7,571.20
6,239.10
1,332.10
21.35%
Shareholder's Funds
7,607.00
6,254.90
1,352.10
21.62%
Minority Interest
5.30
-16.30
21.60
132.52%
Long-Term Borrowings
0.00
2,150.30
-2,150.30
-100.00%
Secured Loans
0.00
237.20
-237.20
-100.00%
Unsecured Loans
0.00
1,913.10
-1,913.10
-100.00%
Deferred Tax Assets / Liabilities
-49.90
-85.20
35.30
41.43%
Other Long Term Liabilities
9.20
1,911.60
-1,902.40
-99.52%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
65.60
119.10
-53.50
-44.92%
Total Non-Current Liabilities
24.90
4,095.80
-4,070.90
-99.39%
Current Liabilities
Trade Payables
274.90
1,004.80
-729.90
-72.64%
Other Current Liabilities
317.60
794.80
-477.20
-60.04%
Short Term Borrowings
273.10
286.60
-13.50
-4.71%
Short Term Provisions
77.90
78.40
-0.50
-0.64%
Total Current Liabilities
943.50
2,164.60
-1,221.10
-56.41%
Total Liabilities
8,580.70
12,499.00
-3,918.30
-31.35%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
4,016.10
7,439.40
-3,423.30
-46.02%
Less: Accumulated Depreciation
1,268.10
2,584.70
-1,316.60
-50.94%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2,698.00
4,854.70
-2,156.70
-44.42%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
225.40
2,714.70
-2,489.30
-91.70%
Intangible assets under development
0.00
915.30
-915.30
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
152.80
43.50
109.30
251.26%
Long Term Loans & Advances
77.70
60.10
17.60
29.28%
Other Non Current Assets
156.80
12.30
144.50
1,174.80%
Total Non-Current Assets
3,310.70
8,921.80
-5,611.10
-62.89%
Current Assets Loans & Advances
Current Investments
320.80
0.00
320.80
0.00%
Inventories
765.80
1,129.20
-363.40
-32.18%
Sundry Debtors
1,246.60
891.50
355.10
39.83%
Cash and Bank
2,176.00
1,088.80
1,087.20
99.85%
Other Current Assets
135.10
331.30
-196.20
-59.22%
Short Term Loans and Advances
625.70
136.40
489.30
358.72%
Total Current Assets
5,270.00
3,577.20
1,692.80
47.32%
Net Current Assets (Including Current Investments)
4,326.50
1,412.60
2,913.90
206.28%
Total Current Assets Excluding Current Investments
4,949.20
3,577.20
1,372.00
38.35%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
8,580.70
12,499.00
-3,918.30
-31.35%
Contingent Liabilities
3.00
368.40
-365.40
-99.19%
Total Debt
273.10
0.00
273.10
0.00%
Book Value per share (adjusted)
424.97
395.88
29.09
7.35%
Annual - Borrowings
Borrowings 273.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -24.81% vs 120.12% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 9.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -1.08% vs 232.14% in Mar 2024

Annual - Fixed Assets
Fixed Assets 2,923.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.24% vs 5.50% in Mar 2024

Annual - Investments
Investments 152.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 59.33% vs 9.85% in Mar 2024

Annual - Current Assets
Current Assets 5,270.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 30.98% vs 34.10% in Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."